Head and Neck Cancer Trial, Recruiting NCT03649048 Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's Condition: Head and Neck Cancer
Back to Head And Neck Cancer

Head and Neck Cancer Trial, Recruiting

NCT03649048
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 18 or older
  • People who are willing and able to sign a written consent form
  • People whose general health and ability to carry out daily activities falls within a certain range, as measured by a standard cancer performance scale (ECOG score of 0–2)
  • People who have been confirmed, through a tissue or cell sample, to have squamous cell carcinoma (a type of cancer)
  • People whose cancer started in the oral cavity, oropharynx, nasal cavity, salivary glands (not including the parotid gland), hypopharynx, larynx, or whose cancer's starting point is unknown
  • People whose treating cancer doctor has judged them suitable to receive high-dose cisplatin chemotherapy
  • People whose treating radiation specialist has judged them suitable to receive radiation treatment aimed at curing the cancer
  • People whose blood counts, liver function, and kidney function meet specific minimum levels (without needing a blood transfusion for at least 7 days before joining the trial) — confirm exact values with the trial site
  • People who have been reviewed at a head and neck cancer specialist team meeting, including assessment by a radiation oncologist and a surgeon, before joining the trial

Who may not be able to join:

  • People with serious other health conditions or other reasons that make chemotherapy or radiotherapy unsafe for them
  • People who have had a head and neck cancer diagnosis within the past 5 years
  • People whose cancer is confirmed or suspected to have started in the nasopharynx (the upper part of the throat behind the nose)
  • People with significant hearing loss, as determined by a clinical assessment
  • People who already use hearing aids
  • People who have moderate or severe nerve damage causing symptoms such as numbness or tingling (peripheral neuropathy grade 2 or higher)
  • People who have had, or are planned to have, chemotherapy before their combined chemotherapy and radiation treatment
  • People who have had radiation treatment to the head or neck area at any time in the past
  • People whose cancer has spread to distant parts of the body
  • People who are unable to attend the full course of radiation treatment or required follow-up appointments
  • People who have had another type of invasive cancer, unless they have been free of that cancer for at least 5 years — exceptions may apply for certain non-invasive or skin cancers (confirm with trial site)
  • People who are unable or unwilling to complete quality-of-life questionnaires
  • People who are pregnant or breastfeeding
  • People who are unable or unwilling to use two methods of contraception at the same time

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 15 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Sara Kuruvilla, MD, London Health Sciences Centre, London Regional Cancer Program

Phone: (519)685-8500

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
5 November 2018
Est. completion
1 September 2028

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

Hearing related quality of life (QOL); Hearing related quality of life (QOL); Compare Incidence of > Grade 2 hearing loss; Compare Incidence of > Grade 1 hearing loss

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov